Clinical applications of magnetic resonance systems with 3 tesla;3-Tesla-magnetresonanztomographie - Klinische anwendungen

Wiener Medizinische Wochenschrift

Volumn 152, Issue SUPPL. 113, 2002, Pages 22-27

  Trattnig, Siegfried ^a  

^a UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

Author keywords

Articular pathology; Brain tumors; Cartilage; Contrast media; Magnetic resonance imaging

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; DIAGNOSTIC AGENT;

ARTICLE; ARTICULAR CARTILAGE; BRAIN METASTASIS; BRAIN TUMOR; CONGENITAL BLOOD VESSEL MALFORMATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HUMAN; LIVER; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE; PHLEBOGRAPHY; SKELETAL MUSCLE; ARTIFACT; BRAIN; BRAIN DISEASE; IMAGE ENHANCEMENT; INSTRUMENTATION; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; PATHOLOGY; PERIPHERAL NEUROPATHY; SENSITIVITY AND SPECIFICITY;

ARTIFACTS; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MUSCULOSKELETAL DISEASES; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 0036434643     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bashir A, Gray ML, Burstein D: Gd-DTPA2- as a measure of cartilage degradation. Magn Reson Med 1996;36:665-673.
2. Beisteiner R, Lanzenberger R, Novak K, Edward V, Windischberger C, Erdler M, Cunnigton R, Gartus A, Streibl B, Moser E, Czech T, Deecke L: Improvement of presurgical patient evaluation by generation of functional magnetic resonance risk maps. Neurosci Lett 2000;290:13-16.
3. Ikeda K, Haughton VM, Ho K, Nowicki BH: Corrleative MR anatomic study of the median nerve. AJR 1996;167:1223-1226.
4. Lin W, Mukherjee P, An H, Yu Y, Wan Y, Vo K, Lee B, Kido D, Haacke EM: Improving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. JMRI 1999;10:118-123.
5. Mlynarik V, Trattnig S, Huber M, Zembsch A, Imhof H: The role of relaxation times in monitoring proteoglycan depletion in articular cartilage. JMRI 1999;10:497-502.
6. Nöbauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, Barth M, Schöggl A, Heimberger K, Matula Ch, Fog A., Kaider A, Trattnig S: Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla. Invest Radiol 2002;37:114-119.
7. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM: Small vessels in the human brain: MR venography with deoxhemoglobln as an intrinsic contrast agent. Radiology 1997;204:272-277.
8. Runge VM: A review of contrast media research in 1999-2000. Invest Radiol 2001;36:123-130.
9. th Annual Meeting of the American Society of Neuroradiology, 1998.
10. Trattnig S, Mlynarik V, Breitenseher M: MRI visualization of proteoglycan depletion in articular cartilage via intravenous administration of Gd-DTPA. Magn Reson Imaging 1999;17:577-583.